Announcements
Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock Offering
December 10, 2025
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 6,900,000 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover over-allotments, bringing the total gross proceeds to Capricor from the offering to approximately US$172.5 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering and H.C. Wainwright & Co. acted as co-manager.
The deal team was led by Rob Carlson (M&A and Private Equity) and included Nick DeAngelis and John E. Walker (M&A and Private Equity).
Contacts
Capabilities
Suggested News & Insights
Sidley Advises Ariel Investments in Its First Close of Project LevelFebruary 9, 2026Sidley Represents Lead Arranger in US$1 Billion Financing to Navitas and Rockhopper for First-Ever Development of the Falklands Islands Sea Lion FieldFebruary 9, 2026Sidley Represents Hennessy Capital Investment Corp. VIII in Its US$241.5 Million IPOFebruary 6, 2026Sidley Represents Optimas Solutions in the Carve-Out Sale of Its International BusinessFebruary 6, 2026Delaware Supreme Court Makes Earnouts Less Risky for Buyers Earnout Decision Partially Reversed Because Buyer Did Not Have to Pursue an Alternative Regulatory PathwayFebruary 5, 2026Sidley Represents Kodiak Gas Services in Its US$675 Million Acquisition of Distributed Power SolutionsFebruary 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory